Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001140361-22-012456
Filing Date
2022-04-01
Accepted
2022-04-01 06:30:21
Documents
1
Period of Report
2021-12-31
Effectiveness Date
2022-04-01

Document Format Files

Seq Description Document Type Size
1 NT 10-K brhc10035898_nt10k.htm NT 10-K 25629
  Complete submission text file 0001140361-22-012456.txt   27002
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-11460 | Film No.: 22795756
SIC: 2834 Pharmaceutical Preparations